Gender Related Differences in the Acute Effects of Delta-9-Tetrahydrocannabinol in Healthy Humans: Sub-Study I (NCT02811510)

🧪 Interventions in This Study

• Placebo (DRUG)
• Dronabinol (DRUG)

Full eligibility criteria are available on the official NIH protocol. View the criteria ↗

📍 All Participating Trial Locations (1 Sites)

• Biological Studies Unit at the VA Connecticut Healthcare System, Yale School of Medicine — West Haven, Connecticut

📞 Contact the Study Coordinator

Phone: (203) 932-5711

Email: carly.hewes@yale.edu

Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.

💰 Cost, Insurance & Patient Rights

• 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
• Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
• Voluntary Participation: You may withdraw at any time without affecting your standard medical care.

More studies in Cannabis

• Ethanol and Cannabinoid Effects on Simulated Driving and Related Cognition: Sub-Study I — West Haven, Connecticut
• Cannabinoids, Learning, and Memory — West Haven, Connecticut
• Ethanol and Cannabinoid Effects on Simulated Driving and Related Cognition — West Haven, Connecticut
• Ethanol and Cannabinoid Effects on Simulated Driving and Related Cognition: Substudy III — West Haven, Connecticut
• The Pharmacokinetics of Single Dose Oral Tetrahydrocannabinol and Cannabidiol — Hamilton, Ontario
• Ethanol and Cannabinoid Effects on Simulated Driving and Related Cognition: Sub-Study II — West Haven, Connecticut

Explore by condition: All Cannabis clinical trials

💡 How to Participate

1. Check the checklist above to see if you may qualify.
2. Contact the study coordinator using the phone/email above.
3. Ask about the visit schedule, what is covered at no cost, and any travel support.
4. Confirm with your own doctor before making a decision.